Skip to main page content
Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

My NCBI Filters
Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
1968 5
1969 6
1970 8
1971 5
1973 2
1974 1
1975 4
1976 9
1977 11
1978 9
1979 3
1980 16
1981 22
1982 34
1983 29
1984 37
1985 44
1986 21
1987 29
1988 39
1989 29
1990 41
1991 40
1992 22
1993 35
1994 38
1995 30
1996 48
1997 49
1998 36
1999 40
2000 42
2001 46
2002 40
2003 28
2004 23
2005 24
2006 15
2007 31
2008 28
2009 32
2010 38
2011 52
2012 47
2013 60
2014 48
2015 55
2016 51
2017 44
2018 25
2019 39
2020 34
2021 47
2022 28
Text availability
Article attribute
Article type
Publication date

Search Results

1,483 results
Results by year
Filters applied: . Clear all
Page 1
Evidence-based clinical practice guidelines for nonalcoholic fatty liver disease/nonalcoholic steatohepatitis 2020.
Tokushige K, Ikejima K, Ono M, Eguchi Y, Kamada Y, Itoh Y, Akuta N, Yoneda M, Iwasa M, Yoneda M, Otsuka M, Tamaki N, Kogiso T, Miwa H, Chayama K, Enomoto N, Shimosegawa T, Takehara T, Koike K. Tokushige K, et al. Among authors: tamaki n. J Gastroenterol. 2021 Nov;56(11):951-963. doi: 10.1007/s00535-021-01796-x. Epub 2021 Sep 17. J Gastroenterol. 2021. PMID: 34533632 Free PMC article. Review.
Reply.
Tamaki N, Kurosaki M, Izumi N. Tamaki N, et al. Clin Gastroenterol Hepatol. 2019 Jun;17(7):1419-1420. doi: 10.1016/j.cgh.2019.01.038. Epub 2019 Jan 30. Clin Gastroenterol Hepatol. 2019. PMID: 30710699 No abstract available.
Clinical Perspectives of Theranostics.
Okamoto S, Shiga T, Tamaki N. Okamoto S, et al. Among authors: tamaki n. Molecules. 2021 Apr 13;26(8):2232. doi: 10.3390/molecules26082232. Molecules. 2021. PMID: 33924345 Free PMC article. Review.
Reply to Wang et al.
Kirino S, Tamaki N, Kurosaki M, Izumi N. Kirino S, et al. Among authors: tamaki n. J Viral Hepat. 2021 Sep;28(9):1335-1336. doi: 10.1111/jvh.13556. Epub 2021 Jun 30. J Viral Hepat. 2021. PMID: 34056812 No abstract available.
Randomised clinical trial: Pemafibrate, a novel selective peroxisome proliferator-activated receptor α modulator (SPPARMα), versus placebo in patients with non-alcoholic fatty liver disease.
Nakajima A, Eguchi Y, Yoneda M, Imajo K, Tamaki N, Suganami H, Nojima T, Tanigawa R, Iizuka M, Iida Y, Loomba R. Nakajima A, et al. Among authors: tamaki n. Aliment Pharmacol Ther. 2021 Nov;54(10):1263-1277. doi: 10.1111/apt.16596. Epub 2021 Sep 16. Aliment Pharmacol Ther. 2021. PMID: 34528723 Clinical Trial.
Early experience of atezolizumab plus bevacizumab therapy in Japanese patients with unresectable hepatocellular carcinoma in real-world practice.
Hayakawa Y, Tsuchiya K, Kurosaki M, Yasui Y, Kaneko S, Tanaka Y, Ishido S, Inada K, Kirino S, Yamashita K, Nobusawa T, Matsumoto H, Kakegawa T, Higuchi M, Takaura K, Tanaka S, Maeyashiki C, Tamaki N, Nakanishi H, Itakura J, Takahashi Y, Asahina Y, Okamoto R, Izumi N. Hayakawa Y, et al. Among authors: tamaki n. Invest New Drugs. 2022 Apr;40(2):392-402. doi: 10.1007/s10637-021-01185-4. Epub 2021 Sep 29. Invest New Drugs. 2022. PMID: 34586531
Absolute quantification of myocardial blood flow.
Yoshinaga K, Manabe O, Tamaki N. Yoshinaga K, et al. Among authors: tamaki n. J Nucl Cardiol. 2018 Apr;25(2):635-651. doi: 10.1007/s12350-016-0591-3. Epub 2016 Jul 21. J Nucl Cardiol. 2018. PMID: 27444500 Review.
1,483 results